Harbour Investments’s Trillium Therapeutics Inc. TRIL Stock Holding History

Harbour Investments’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,430	Closed	-$25K	–	4023
2021 Q3	$25K	Buy	1,430 +8	+0.6%	+$93	﹤0.01%	2187
2021 Q2	$14K	Hold	1,422	–	–	﹤0.01%	2564
2021 Q1	$15K	Buy	+1,422	New	+$17.6K	﹤0.01%	2386

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Harbour Investments's TRIL Position: Q4 2021 in Review

Harbour Investments sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 1,430 shares — an estimated $25K sold.

Harbour Investments first reported a position in TRIL in Q1 2021 and held it in 3 quarters. The position peaked at $25K in Q3 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

Harbour Investments reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
Harbour Investments sold 1,430 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $25K.
Harbour Investments first reported a position in Trillium Therapeutics Inc. in Q1 2021 and held it in 3 quarters.
Harbour Investments's Trillium Therapeutics Inc. position peaked at $25K in Q3 2021.
2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on Harbour Investments's 13F filing for Q4 2021, filed 16 Feb 2022.